Gunpowder Capital Management’s Amgen AMGN Stock Holding History

Gunpowder Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10	Closed	-$3.27K	–	410
2025 Q4	$3.27K	Buy	+10	New	+$3.17K	﹤0.01%	344

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Gunpowder Capital Management's AMGN Position: Q1 2026 in Review

Gunpowder Capital Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 10 shares — an estimated $3.27K sold.

Gunpowder Capital Management first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $3.27K in Q4 2025. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Gunpowder Capital Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Gunpowder Capital Management sold 10 Amgen shares in Q1 2026, an estimated $3.27K.
Gunpowder Capital Management first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
Gunpowder Capital Management's Amgen position peaked at $3.27K in Q4 2025.
3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Gunpowder Capital Management's 13F filing for Q1 2026, filed 14 May 2026.